Numerous investigations have evaluated the functional role of MEG3 as a tumor suppressor in various types of human cancers, such as gastric cancer, lung cancer, glioma, cervical cancer, bladder cancer, and HCC [103,104,105,106,107,108,109]. This evidence concerns the gene MEG3 and hepatocellular carcinoma.